Acute Psychosis
Critical Alerts
- Always rule out organic causes first: Up to 10% of "psychiatric" presentations have medical etiology
- Delirium mimics psychosis: Fluctuating consciousness = NOT primary psychosis
- Medical clearance is essential: Check glucose, electrolytes, tox screen, vital signs
- Never assume "known psychiatric patient": New organic cause may be present
- Excited delirium syndrome: Can lead to sudden death - requires immediate intervention
- Serotonin syndrome and NMS: Life-threatening medication reactions
Key Diagnostics
| Test | Purpose | Significance |
|---|---|---|
| Fingerstick glucose | Hypoglycemia | Rapid, reversible cause |
| Vital signs | Fever, tachycardia, hypoxia | Suggest medical cause |
| Urine drug screen | Substance-induced psychosis | Common in ED setting |
| CMP | Electrolytes, glucose, renal/hepatic | Metabolic causes |
| TSH | Thyroid dysfunction | Hyper/hypothyroidism |
| CT Head | Structural lesions | If focal signs, first episode, altered LOC |
Emergency Treatments
| Situation | Treatment | Dose |
|---|---|---|
| Agitation - Cooperative | Oral olanzapine | 5-10mg PO |
| Agitation - Uncooperative | Haloperidol + Lorazepam | 5mg + 2mg IM |
| Severe agitation | Droperidol | 2.5-5mg IM |
| Behavioral emergency | Ketamine | 4-5 mg/kg IM |
| Known benzodiazepine responsive | Lorazepam | 2mg IM/IV |
Overview
Acute psychosis is a syndrome characterized by a break from reality, manifesting as delusions, hallucinations, disorganized speech, or grossly disorganized/catatonic behavior. In the emergency department, the priority is ensuring safety, ruling out life-threatening organic causes, and providing appropriate pharmacological intervention.
Classification
By Etiology:
| Category | Examples |
|---|---|
| Primary Psychiatric | Schizophrenia, schizoaffective, brief psychotic disorder |
| Bipolar | Manic or depressive episode with psychotic features |
| Substance-Induced | Stimulants, cannabis, hallucinogens, alcohol withdrawal |
| Medical/Organic | Delirium, encephalitis, metabolic, structural lesions |
| Medication-Induced | Steroids, dopamine agonists, anticholinergics |
By Presentation:
- First-episode psychosis: Initial presentation; requires thorough medical workup
- Recurrent episode in known condition: Still requires medical screen
- Acute-on-chronic: Exacerbation of baseline; medication non-adherence common
Epidemiology
- Lifetime risk of psychotic disorder: 3% of population
- Schizophrenia prevalence: 1% worldwide
- Age of onset: Males 15-25 years; females 25-35 years
- ED presentations: 10-15% of psychiatric emergencies involve psychosis
- Substance-induced: 25-50% of psychosis presentations in urban EDs
Etiology
Primary Psychiatric Disorders:
- Schizophrenia (most common chronic cause)
- Schizoaffective disorder
- Brief psychotic disorder (<1 month)
- Schizophreniform (1-6 months)
- Bipolar disorder with psychotic features
- Major depression with psychotic features
- Delusional disorder
Substance-Related:
| Substance | Presentation |
|---|---|
| Stimulants (methamphetamine, cocaine) | Paranoid delusions, tactile hallucinations |
| Cannabis (high-potency) | Paranoid ideation, anxiety |
| Hallucinogens (LSD, psilocybin) | Visual hallucinations, synesthesia |
| Alcohol withdrawal | Visual hallucinations, tremor, delirium tremens |
| PCP/Ketamine | Dissociation, bizarre behavior, nystagmus |
| Synthetic cannabinoids | Agitation, aggression, unpredictable behavior |
Medical Causes (MUST Exclude):
| Category | Examples |
|---|---|
| Infectious | Encephalitis (HSV, HIV), meningitis, sepsis, UTI in elderly |
| Metabolic | Hypoglycemia, hypo/hypernatremia, hypercalcemia, uremia, hepatic encephalopathy |
| Endocrine | Thyroid storm, myxedema, adrenal crisis |
| Neurological | Seizures (ictal/post-ictal), stroke, TBI, brain tumor |
| Autoimmune | Anti-NMDA receptor encephalitis, lupus cerebritis |
| Toxic | CO poisoning, heavy metals, withdrawal syndromes |
Neurobiological Basis
Dopamine Hypothesis:
- Excessive dopamine activity in mesolimbic pathway → positive symptoms (hallucinations, delusions)
- Decreased dopamine in prefrontal cortex → negative symptoms (flat affect, anhedonia)
- Antipsychotics work primarily via D2 receptor blockade
Glutamate Hypothesis:
- NMDA receptor hypofunction contributes to psychotic symptoms
- Explains why PCP/ketamine (NMDA antagonists) cause psychosis
Serotonin Involvement:
- 5-HT2A receptor activation contributes to hallucinations
- Atypical antipsychotics have 5-HT2A antagonism
Substance-Induced Mechanisms
| Substance | Mechanism |
|---|---|
| Stimulants | Massive dopamine release, neurotoxicity |
| Cannabis | CB1 receptor activation, dopamine modulation |
| Hallucinogens | 5-HT2A agonism |
| Alcohol withdrawal | GABA under-activity, glutamate excess |
| Anticholinergics | Cholinergic blockade, delirium |
Core Psychotic Symptoms
Positive Symptoms:
| Symptom | Description |
|---|---|
| Delusions | Fixed false beliefs not amenable to logic |
| Hallucinations | Perceptions without stimulus (auditory most common) |
| Disorganized speech | Tangential, loose associations, word salad |
| Disorganized behavior | Unusual motor behavior, inappropriate affect |
Types of Delusions:
Types of Hallucinations:
Negative Symptoms (More chronic, less ED-relevant):
Agitated vs. Non-Agitated Presentation
| Feature | Agitated | Non-Agitated |
|---|---|---|
| Behavior | Combative, threatening, pacing | Withdrawn, catatonic, disorganized |
| Risk | Acute danger to self/others | Safety risk from inability to care for self |
| Urgency | Immediate pharmacological intervention | Time for evaluation, oral medications |
| Staff safety | High priority | Less immediate concern |
Physical Examination
Vital Signs (Abnormal suggests medical cause):
Mental Status Examination:
| Domain | Assessment |
|---|---|
| Appearance | Hygiene, clothing, motor activity |
| Behavior | Cooperative, agitated, catatonic |
| Speech | Rate, volume, coherence |
| Mood/Affect | Stated mood, observed affect (flat, labile) |
| Thought process | Linear vs. disorganized, loosening |
| Thought content | Delusions, suicidal/homicidal ideation |
| Perception | Hallucinations, illusions |
| Cognition | Orientation, attention, memory |
| Insight | Awareness of illness |
| Judgment | Decision-making capacity |
Neurological Examination:
Indicators of Medical/Organic Cause
| Finding | Concern | Action |
|---|---|---|
| Altered level of consciousness | Delirium, not primary psychosis | Full medical workup |
| Visual hallucinations predominant | Organic cause | CT head, metabolic workup |
| Acute onset (hours) | Medical cause | Immediate evaluation |
| Age >0 first episode | Organic etiology | Extensive medical workup |
| New focal neurological signs | Structural lesion | Urgent neuroimaging |
| Vital sign abnormalities | Medical illness | Address medical cause |
| Fluctuating symptoms | Delirium | Not primary psychosis |
| Recent head trauma | TBI, subdural | CT head |
| Immunocompromised | Opportunistic CNS infection | Lumbar puncture, imaging |
Psychiatric Emergencies
| Finding | Concern | Action |
|---|---|---|
| Command hallucinations to harm | Imminent violence | Security, pharmacological restraint |
| Active suicidal ideation with plan | Suicide risk | 1:1 observation, safety measures |
| Catatonic stupor | Lethal catatonia | Lorazepam trial, consider ECT |
| NMS features (rigidity, fever, AMS) | Neuroleptic malignant syndrome | Stop antipsychotics, supportive care |
| Excited delirium | Sudden death risk | Immediate cooling, sedation |
Medical Mimics of Psychosis
| Condition | Key Distinguishing Features |
|---|---|
| Delirium | Fluctuating attention, altered LOC, usually acute |
| Anti-NMDA receptor encephalitis | Young women, prodrome, movement disorder |
| Hypoglycemia | Rapid onset, diaphoresis, responds to glucose |
| Thyrotoxicosis | Tremor, weight loss, heat intolerance |
| Wernicke's encephalopathy | Ataxia, ophthalmoplegia, confusion, alcohol use |
| Hepatic encephalopathy | Asterixis, liver disease, elevated ammonia |
| Temporal lobe epilepsy | Ictal automatisms, post-ictal confusion |
| Brain tumor | Gradual onset, focal signs, headache |
| Stroke | Sudden onset, focal deficits |
| HIV encephalopathy | Risk factors, opportunistic infections |
| Syphilis | History, positive serology |
Psychiatric Differential
| Condition | Key Features |
|---|---|
| Schizophrenia | > months symptoms, deteriorating function |
| Brief psychotic disorder | <1 month, often stress-related |
| Bipolar mania | Euphoria, decreased sleep, grandiosity |
| Psychotic depression | Mood congruent delusions, depression prominent |
| PTSD with dissociation | Trauma history, flashbacks |
| Borderline personality | Stress-related transient psychosis |
| Malingering | Secondary gain, inconsistent symptoms |
Immediate Safety and Stabilization
- Ensure scene safety for staff and patient
- De-escalation techniques
- Physical restraints only as last resort
- Rapid assessment of dangerous behaviors
Medical Clearance Algorithm
All Patients:
- Fingerstick glucose
- Vital signs (T, HR, BP, RR, O2 sat)
- Urine drug screen
- Basic metabolic panel
- Mental status examination
First Episode Psychosis or High Suspicion for Organic:
| Test | Indication |
|---|---|
| CBC | Infection, WBC abnormalities |
| LFTs | Hepatic encephalopathy |
| TSH | Thyroid disorders |
| Ammonia | Hepatic encephalopathy |
| CT Head | Structural CNS pathology |
| Lumbar puncture | Encephalitis, meningitis |
| EEG | Seizures, encephalopathy |
| HIV, syphilis serology | CNS infections |
| B12 | Deficiency psychosis |
| Urinalysis | UTI (elderly) |
Consider in Young Patients with Unusual Presentation:
- Anti-NMDA receptor antibodies
- Autoimmune encephalitis panel
- MRI brain
Clinical Decision Rules
Organic vs Primary Psychiatric Psychosis:
| Factor | Favors Organic | Favors Primary |
|---|---|---|
| Age of onset | >0 years | 15-35 years |
| Onset speed | Acute (hours to days) | Gradual (weeks to months) |
| Consciousness | Fluctuating/impaired | Clear |
| Orientation | Impaired | Usually intact |
| Visual hallucinations | Common | Less common |
| Vital signs | Abnormal | Usually normal |
| Medical history | Risk factors present | None |
| Response to antipsychotic | Poor | Good |
Principles of Management
- Safety first: Staff and patient safety paramount
- De-escalation: Verbal techniques before medications
- Rule out organic causes: Medical workup
- Pharmacological intervention: When needed for safety
- Avoid unnecessary restraints: Medication preferable
- Least restrictive environment: When safe
De-escalation Techniques
- Speak calmly, use patient's name
- Maintain safe distance, avoid cornering
- Offer choices (oral medication, sitting)
- Remove stimuli (noise, crowds)
- Listen to concerns, validate emotions
- Clear communication, set limits
- Show respect and empathy
Pharmacological Management
Oral Medications (Cooperative Patient):
| Medication | Dose | Onset | Notes |
|---|---|---|---|
| Olanzapine ODT | 5-10mg | 15-45 min | Preferred if willing |
| Risperidone | 1-2mg | 30-60 min | Liquid available |
| Lorazepam | 1-2mg | 15-30 min | Undifferentiated agitation |
| Haloperidol | 5mg | 30-60 min | Older agent, effective |
Intramuscular Medications (Uncooperative Patient):
| Medication | Dose | Onset | Notes |
|---|---|---|---|
| Olanzapine | 10mg IM | 15-30 min | Avoid with benzodiazepines |
| Haloperidol + Lorazepam | 5mg + 2mg IM | 15-20 min | Classic "B52" (add diphenhydramine 50mg) |
| Droperidol | 2.5-5mg IM | 10-20 min | Rapid, effective; QTc monitoring |
| Ziprasidone | 10-20mg IM | 15-30 min | Lower EPS risk |
| Ketamine | 4-5 mg/kg IM | 5 min | Severe agitation, excited delirium |
Special Situations:
| Scenario | Preferred Agent | Rationale |
|---|---|---|
| Unknown etiology | Lorazepam | Safe if organic cause |
| Alcohol withdrawal | Benzodiazepines | Treats underlying withdrawal |
| Stimulant intoxication | Benzodiazepines | Avoid antipsychotics initially |
| Known schizophrenia | Antipsychotic | Addresses underlying condition |
| Pregnant | Haloperidol or olanzapine | Better safety data |
| Elderly | Lower doses of all | Start low, go slow |
Safety Considerations
- QTc prolongation: Droperidol, haloperidol, ziprasidone
- Respiratory depression: Benzodiazepines, especially with opioids
- EPS/acute dystonia: Typical antipsychotics; treat with diphenhydramine/benztropine
- NMS risk: All antipsychotics; watch for rigidity, fever
- Don't combine IM olanzapine with benzodiazepines: Cardiorespiratory depression
Physical Restraints
- Last resort only
- Documentation required: Indication, less restrictive measures tried
- Time-limited: Reassess every 15-30 minutes
- Continuous monitoring: Vital signs, respiratory status
- Supine positioning increases mortality: Avoid prone restraint
Admission Criteria
Psychiatric Admission:
- First episode psychosis requiring stabilization
- Danger to self (suicidal ideation/behavior)
- Danger to others (homicidal ideation/behavior)
- Unable to care for self due to psychosis
- Medication non-adherence requiring supervised treatment
- Failed outpatient management
Medical Admission:
- Identified medical cause requiring treatment
- Uncertain etiology requiring further workup
- NMS, serotonin syndrome, excited delirium
- Delirium requiring ongoing evaluation
Discharge Criteria
- Medical causes excluded or treated
- No imminent danger to self or others
- Able to care for basic needs
- Support system in place
- Outpatient follow-up arranged
- Medication plan established
Involuntary Commitment
- Laws vary by jurisdiction
- Generally requires:
- Mental illness present
- Danger to self or others OR unable to care for self
- Less restrictive alternatives not appropriate
- Document clearly the specific criteria met
Follow-Up Recommendations
| Situation | Follow-Up |
|---|---|
| First episode psychosis | Psychiatry within 1-2 days |
| Known patient stable on medications | Psychiatry within 1 week |
| Substance-induced | Psychiatry + addiction medicine |
| Medication change | Psychiatry within 3-5 days |
Condition Explanation (For Families)
- "Your family member is experiencing psychosis, which means their brain is having difficulty distinguishing what's real from what isn't."
- "This can be caused by mental illness, substances, or physical medical conditions."
- "With proper treatment, many people with psychosis can lead stable lives."
Medication Education
- Explain purpose of medications
- Common side effects to expect
- Importance of adherence
- Warning signs requiring return
Safety Planning
- Remove access to weapons
- Supervise medications
- Have crisis numbers available
- Develop a crisis plan
Warning Signs Requiring Return
- Worsening symptoms
- Refusal to eat or drink
- Medication side effects (stiffness, fever, repetitive movements)
- Suicidal or aggressive thoughts
- Inability to care for self
Adolescents
- First episode often presents in adolescence
- Differentiate from substance use
- May present with prodromal symptoms
- Early intervention programs improve outcomes
- Involve family when possible
Elderly
- Always assume organic cause until proven otherwise
- Delirium extremely common
- Lower doses of all medications
- UTI is common trigger for altered mental status
- Anticholinergic effects more pronounced
- Increased sensitivity to antipsychotics
Pregnant Patients
- Teratogenicity considerations
- Haloperidol has longest safety record
- Olanzapine, risperidone relatively safe
- Avoid valproate, carbamazepine
- Involve obstetrics
- Untreated psychosis risks outweigh medication risks
Patients with Intellectual Disability
- May have difficulty communicating symptoms
- Baseline behavior important from caregivers
- Lower threshold for medical workup
- Adjust communication style
- Consider nonverbal signs of distress
Substance Use Disorder Comorbidity
- Extremely common (50% of schizophrenia patients)
- Complicates treatment
- May need dual diagnosis program
- Risk of withdrawal syndromes
Performance Indicators
| Metric | Target | Rationale |
|---|---|---|
| Time to de-escalation attempt | 100% | Safety outcome |
| Medical clearance completed | 100% | Avoid missing organic cause |
| Glucose checked before antipsychotic | 100% | Avoid treating hypoglycemia with sedation |
| Restraint use rate | Minimize | Less restrictive care |
| Time in restraints | <30 min | Patient dignity and safety |
| Substance screen completed | >0% | Identify substance-induced causes |
Documentation Requirements
- Safety assessment (SI/HI documented)
- Medical clearance workup and results
- Mental status examination
- De-escalation attempts
- Medication administration times and effects
- Restraint justification if used
- Capacity assessment
- Disposition decision and rationale
- Follow-up arrangements
Diagnostic Pearls
- "All psychosis is organic until proven otherwise": Always medical workup
- Fluctuating consciousness = delirium, not psychosis: Key distinction
- Visual hallucinations suggest organic cause: Be suspicious
- First episode over 40 = medical etiology likely: Extensive workup
- "Drug screen negative" doesn't exclude substance use: Synthetic drugs may not be detected
- Anti-NMDA encephalitis: Think of in young women with psychiatric + movement signs
Treatment Pearls
- De-escalation first: Often effective and safer
- Offer oral before IM: Less traumatic, builds rapport
- Benzodiazepines if unsure of etiology: Safe for organic causes
- Avoid IM olanzapine + IM benzodiazepine together: Cardiorespiratory depression
- 5-10-15-20 rule: Reassess effect every 15-20 minutes before re-dosing
- "Start low, go slow" in elderly: Paradoxical worsening possible
Disposition Pearls
- Psychiatric hold criteria vary by state: Know your local laws
- Document danger clearly: Specific behaviors and statements
- Family involvement improves outcomes: Engage when appropriate
- Outpatient follow-up is essential: Arrange before discharge
- Substance-induced psychosis: Resolves with abstinence but may unmask primary disorder
- Nordstrom K, et al. Medical Evaluation and Triage of the Agitated Patient: Consensus Statement of the American Association for Emergency Psychiatry Project BETA Medical Evaluation Workgroup. West J Emerg Med. 2012;13(1):3-10.
- Wilson MP, et al. The Psychopharmacology of Agitation: Consensus Statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup. West J Emerg Med. 2012;13(1):26-34.
- Garriga M, et al. Assessment and management of agitation in psychiatry: Expert consensus. World J Biol Psychiatry. 2016;17(2):86-128.
- Marder SR. First-episode psychosis. UpToDate. 2024.
- Correll CU, et al. Efficacy and safety of intramuscular aripiprazole in adult patients with acute agitation. J Clin Psychiatry. 2019;80(1).
- NICE Guideline. Violence and aggression: short-term management in mental health, health and community settings. 2015.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). 2013.
- Zun LS. Evidence-based review of pharmacotherapy for acute agitation. Part 1: Onset of efficacy. J Emerg Med. 2018;54(3):364-374.